Skip to main content

Table 2 Morphometric analysis of lungs from CSF-1-treated mice after 7 days of neonatal hyperoxia exposure

From: The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure

  

Normoxia

Hyp + PBS

Hyp + CSF-1

P11

% Tissue

50.66 ± 1.61

53.62 ± 2.99

52.98 ± 1.90

 

% Airspace

49.34 ± 1.61

46.38 ± 2.99

47.02 ± 1.90

 

MLI

88.59 ± 2.42

94.33 ± 2.37

87.42 ± 0.99

P35

% Tissue

36.97 ± 1.29

39.15 ± 2.01

35.92 ± 0.87

 

% Airspace

63.03 ± 1.29

60.85 ± 2.01

64.08 ± 0.87

 

MLI

64.99 ± 1.78

68.67 ± 1.64

67.34 ± 1.63

  1. Morphometric estimation of percentage tissue, percentage airspace and mean linear intercept (MLI) at P11 (n = 4 lungs/treatment) and P35 (n = 6-7 lungs/treatment) in newborn mice exposed to normoxia or hyperoxia for 7 days followed by either CSF-1 or PBS treatment for 5 consecutive days. No significant changes were observed in the morphometric parameters examined amongst the three treatment groups. Data were analysed using one-way ANOVAs and Tukey’s post-hoc tests.